Insight

Dec 20, 2024, 13:52

Biosimilars offer innovative treatment options for cancer care – UICC

Union for International Cancer Control (UICC) posted the following on LinkedIn:

“Biosimilars may be the key to expanding treatment options for cancer patients worldwide. But what are they, and how do they work? Discover the science behind these innovative therapies and their potential to reshape cancer care.

Watch this insightful content, produced with the support of Celltrion Inc., as part of the Rewriting Cancer series produced by BBC StoryWorks and presented by the Union for International Cancer Control (UICC).”

BBC StoryWorks biosimilars cancer cancer innovation cancer treatment Celltrion Inc. global oncology innovative therapies OncoDaily Oncology patient care Rewriting Cancer series UICC

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage